Oral fenofibrate for hyperbilirubinemia in term neonates: A single-blind randomized controlled trial

BACKGROUND: Hyperbilirubinemia is common in the neonatal period; however, delayed diagnosis or inadequate treatment can cause irreparable damage to the neonates. We aimed to evaluate the efficacy of oral fenofibrate for hyperbilirubinemia in term neonates. METHODS: This single-blind randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadat, Seyed Hossein, Goodarzi, Rakhshaneh, Gharaei, Babak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130838/
https://www.ncbi.nlm.nih.gov/pubmed/37125058
http://dx.doi.org/10.1017/cts.2023.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130838/
https://www.ncbi.nlm.nih.gov/pubmed/37125058
http://dx.doi.org/10.1017/cts.2023.35

Ejemplares similares